PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 4272 (118th)

Stop Fentanyl Now Act of 2023

referredUnited States· United States Congress· EN

Introduced

22 June 2023

Last action

23 June 2023 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Sheila Jackson Lee, Rep. Nadler, Jerrold [D-NY-12], Dwight Evans, Adriano Espaillat, Glenn Ivey, Sen. Schiff, Adam B. [D-CA], Rep. Ross, Deborah K. [D-NC-2], Rep. Crockett, Jasmine [D-TX-30], Rep. Davis, Danny K. [D-IL-7], Rep. Cohen, Steve [D-TN-9], Sheila Cherfilus-McCormick, Frederica Wilson, Rep. Doggett, Lloyd [D-TX-37], Rep. Beatty, Joyce [D-OH-3], Rep. Mfume, Kweisi [D-MD-7], Jonathan Jackson, Rep. Neguse, Joe [D-CO-2], Rep. Johnson, Henry C. "Hank" [D-GA-4], Bennie Thompson, Emanuel Cleaver, Sydney Kamlager-Dove, Emilia Sykes, Rep. Horsford, Steven [D-NV-4], Rep. Sewell, Terri A. [D-AL-7], Rep. Carter, Troy A. [D-LA-2], Rep. Clarke, Yvette D. [D-NY-9], Rep. McBath, Lucy [D-GA-6], Juan Vargas, Rep. Garcia, Robert [D-CA-42], Shri Thanedar, Rep. Williams, Nikema [D-GA-5], Jesús García, Raúl Grijalva, Donald Payne, Rep. Carson, André [D-IN-7], Rep. Raskin, Jamie [D-MD-8], Barbara Lee, Rep. Meeks, Gregory W. [D-NY-5], Rep. Lieu, Ted [D-CA-36], Jamaal Bowman, Gwen Moore, Brad Sherman, Shontel Brown, Jahana Hayes, Al Green

Subjects

Discovery layer

Source updated

5 December 2025

Official sourceDownload fileView documentsShare

Summary

Stop Fentanyl Now Act of 2023 This bill establishes several programs and requirements to address the use of fentanyl and related substances. For example, the bill expands the Comprehensive Opioid Abuse Grant Program in the Department of Justice (DOJ) to include training and resources for teachers on how to carry and administer opioid overdose reversal drugs (e.g., naloxone). DOJ must also increase resources and establish an interagency task force for law enforcement agencies to combat the trafficking of fentanyl, fentanyl-related, and fentanyl-laced substances. Additionally, the Department of Health and Human Services must develop a national strategy to prevent the use of these substances, award grants to state and localities for treatment programs for those who are addicted to these substances, and research the health effects of these substances. The bill also increases criminal penalties for adulterating or misbranding drugs if the violation results in serious bodily injury or death (imprisonment of up to 10 years, a fine of up to $1 million, or both for violations that result in serious bodily injury, and up to life imprisonment, a fine of up to $5 million, or both for violations that result in death). Penalties are higher for violations that include the intent to defraud or mislead. The bill adds up to 5 years of additional imprisonment if the violation involves drugs that are promoted or sold online. Furthermore, the bill exempts the possession, sale, or purchase of fentanyl drug testing equipment, including test strips, from criminal penalties under the Controlled Substances Act.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 22 June 2023

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 22 June 2023

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 22 June 2023

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 23 June 2023

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.